Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Iraqi study maps liver parasite infections to boost local care

NCT ID NCT07369674

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at the medical records of 350 people in Najaf, Iraq, who had liver hydatid cysts—a parasitic infection common in the region. Researchers wanted to learn more about who gets the disease and how it shows up, so doctors can better treat and prevent it. The study did not test any new treatments, but gathered important information to guide future health strategies.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

350 people

The number who actually took part.

Started

Feb 2021

Finished

Mar 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

This retrospective, observational study was conducted on a total of 350 patients diagnosed with liver hydatid cysts. The study was carried out at multiple centers in Najaf City, Iraq, including major governmental surgical hospitals and specialized centers, covering the period from February 2021 to June 2024.

Ages

9 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: All patients of any age or gender with a radiologically or surgically confirmed diagnosis of liver hydatid cyst Exclusion Criteria: Patients with hydatid cysts located exclusively in extra-hepatic sites (e.g., brain, lung, bone, spleen, or muscle). Patients with severe chronic comorbidities or incomplete medical records were also excluded to ensure data integrity

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hydatid cyst, hepatic are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University of Alkafeel

    Najaf, 00964, Iraq